Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09YDO
|
|||
| Former ID |
DIB005066
|
|||
| Drug Name |
Quinotolast
|
|||
| Synonyms |
Aslock; Quinotalast; FK-021; FR-71021
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Asthma [ICD-11: CA23; ICD-10: J45, J45.8; ICD-9: 493] | Phase 3 | [1] | |
| Company |
Fujisawa Pharmaceutical Co Ltd
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H12N6O3
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)OC2=C3C=CC=CN3C(=O)C(=C2)C(=O)NC4=NNN=N4
|
|||
| InChI |
1S/C17H12N6O3/c24-15(18-17-19-21-22-20-17)12-10-14(26-11-6-2-1-3-7-11)13-8-4-5-9-23(13)16(12)25/h1-10H,(H2,18,19,20,21,22,24)
|
|||
| InChIKey |
ZUPLNRDTYQWUHP-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 101193-40-2
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Histamine/peptide leukotriene release (His/p-LT rele) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Studies on structures of urinary metabolites of quinotolast, a new oral anti-allergics. Yakugaku Zasshi. 1993 Aug;113(8):579-85. | |||
| REF 2 | Effects of quinotolast, a new orally active antiallergic drug, on experimental allergic models. Jpn J Pharmacol. 1993 Sep;63(1):73-81. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.